Menu

News Items

A great distinction for a member of HPhos

zergioti chequeteamSPIE

PhosPrint came in third place at the 13th annual SPIE Startup Challenge, winning $2,500, with its novel bio-printing technology that repairs in vivo human tissue during surgery.

CEO and Co-Founder of PhosPrint, Ioanna Zergioti, presented PhosPrint's pitch during the challenge and Clinical Director, Apostolos Klinakis, represented PhosPrint at the event. ‘’It was a great experience for me,’’ noted Ioanna Zerioti. ‘’It was exciting for us to have the opportunity to present our startup at the SPIE Startup Challenge. It was great to work with the judges, and to get feedback from senior investors in the field.’’

The SPIE Startup Challenge, a pitch competition held annually at Photonics West, showcases new businesses, products, and technologies that address critical needs by utilizing photonics in the areas of healthcare and deep tech. It was supported by Founding Partner Jenoptik, Lead Sponsors Edmund Optics, Hamamatsu, MKS Instruments and Thorlabs; and Supporting Sponsors NextCorps Luminate and Photonics Media.

Read more

 

A great success for a member of HPhos

PhosPrint PhosPrint largeEIC logo

 

The spin-off PhosPrint is one among the 75 SMEs selected for funding in the most recent applications from EIC Accelerator new wave of deep tech start-ups.

PhosPrint is the first Greek company selected by the EIC Accelerator scheme and will translate their research results on the Laser bioprinting device and in vivo applications into pre-clinical and clinics trials.

The 3D laser printer that PhosPrint has developed, allows the successful printing of 100M cells in just 1.6 minutes, targeting enterocystoplasty and bladder cancer. The printing of cells takes place during in vivo surgery and has been effectively tested in pigs. Full adaptation of this method from medical facilities and hospitals after the preclinical trials, prerequires the successful completion of three stages of clinical trials.

PhosPrint’s funding from EIC Accelerator will be used towards the first clinical trial phase.

Read more

Photonics21 towards Horizon Europe online seminar

 

online seminar site front post

 

“As physical events are still not a good option for the rest of the year, Photonics21 decide to host the online meeting "Photonics21 towards Horizon Europe" on November 5th, 2020 from 10am - 12pm”

Read more: Photonics21 towards Horizon Europe online seminar

Alert – Potential 30% reduction in funding support by European Commission for future Photonics Partnership 2021-2027 in Horizon Europe

 

Alert Potential 30 reduction

 

The recent European Commission industry strategy “A New Industrial Strategy for Europe” clearly recognized Photonics technologies as a key enabling technology for the digital transformation of European industry stating, “The EU will support the development of key enabling technologies that are strategically important for Europe’s industrial future…including Photonics“.

Read more: Alert – Potential 30% reduction in funding support by European Commission for future Photonics...